Skip to main content
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY.

Russell MD. The Lancet Rheumatology 2026;:https://doi.org/10.1016/S2665-9913(26)00142-6.

Published on 13/7/2026

Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.

Parker EPK. eBioMedicine 2026;:https://doi.org/10.1016/j.ebiom.2026.106327.

Published on 13/7/2026

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19.

Agyeman AA. British Journal of Clinical Pharmacology 2026;92(7):2390-2402.

Published on 21/7/2026

Community-delivered hyperbaric oxygen therapy for people affected by long COVID: a pilot study.

Gale N. British Journal of Nursing 2026;35(12):626-632.

Published on 2/8/2026

Effects of antibiotic treatment on clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

Dona D. The Lancet Microbe 2026;:https://doi.org/10.1016/j.lanmic.2026.101358.

Published on 16/6/2026

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

Hayden FG. New England Journal of Medicine 2026;394(19):1905-1915.

Published on 15/6/2026


...
4
5
6
7
8
...